about
Structural feature of bent DNA recognized by HMGB1Total synthesis of (-)-muraymycin D2 and its epimer.Synthesis of tunicaminyluracil derivatives.Fine synthetic nucleoside chemistry based on nucleoside natural products synthesis.Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity.Design and synthesis of diketopiperazine and acyclic analogs related to the caprazamycins and liposidomycins as potential antibacterial agents.Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition.GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.Total synthesis of plusbacin A3 and its dideoxy derivative using a solvent-dependent diastereodivergent Joullié-Ugi three-component reaction.Total Synthesis of Tunicamycin V.Total Synthesis and Antibacterial Investigation of Plusbacin A3.Function-Oriented Synthesis: How to Design Simplified Analogues of Antibacterial Nucleoside Natural Products?Synthesis of 3'-beta-carbamoylmethylcytidine (CAMC) and its derivatives as potential antitumor agents.[Synthetic study of nucleoside antibiotics]Synthesis of L-epi-capreomycidine derivatives via C-H aminationTotal synthesis of pacidamycin D by Cu(I)-catalyzed oxy enamide formationSynthesis of isoxazolidine-containing uridine derivatives as caprazamycin analoguesA Synthesis Strategy for the Production of a Macrolactone of Gulmirecin A via a Ni(0)-Mediated Reductive Cyclization ReactionNovel adenosine-derived inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenaseSynthesis of All Stereoisomers of Monomeric Spectomycin A1/A2 and Evaluation of Their Protein SUMOylation-Inhibitory ActivityTunicamycin: chemical synthesis and biosynthesisTotal Synthesis of Echinomycin and Its Analogues
P50
Q27667133-4672FAF8-F4D2-4FBA-A63B-B86CFC488E2CQ43167397-6AA627E1-A045-4041-A39D-C2EB6309C256Q44813614-EA1A79E1-CBA6-4D69-867E-F82B321E5FF5Q46452993-3CD937D8-3407-4628-BA70-E93A83BAAC6EQ46841809-92B82601-9ACE-46DF-9097-463A1A6026D7Q46975408-32EA9B44-48B6-4071-A957-084470595087Q47106457-B9F998A1-D1D7-4AE4-9089-F93DAFD6886DQ49829949-068A5870-9F72-4BC8-B1D5-E26850AA55F3Q49851520-A0C98609-3505-4EAF-B026-F02224975416Q50551106-B52D5E35-A11A-4BFD-9977-71A48606C474Q50617691-D6D6FFF0-B0CB-4538-B196-58C75D5935CFQ50865707-25DA8BA2-D040-4AFE-A7F1-75E9AE0622BAQ53630824-27B679A9-3AAB-4A69-BB1E-3C5A6E804615Q80037028-5E131D1E-77DA-4830-A400-53506B57C6E4Q84516069-3047A074-F7A5-4BFC-9707-9ED546395E7DQ84915167-1BC589D3-5A79-4B78-ADF6-2007E2CDB989Q86065085-C96D2539-782F-4F3D-8253-C0985C5EB6DBQ90258393-6B5E7070-2E68-45DC-86D7-ADC41AF5FDD1Q91809918-817EA661-0DD2-4031-B2C2-B5426AC2B0D3Q92468679-CA027C67-585F-4951-9D52-DA230110350EQ93001055-51A9183D-3E80-40F2-8FFC-F23A5EB5CE18Q94605109-9D3F08ED-8E9D-4D97-B039-07E360D36CE5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Satoshi Ichikawa
@ast
Satoshi Ichikawa
@en
Satoshi Ichikawa
@es
Satoshi Ichikawa
@nl
Satoshi Ichikawa
@sl
type
label
Satoshi Ichikawa
@ast
Satoshi Ichikawa
@en
Satoshi Ichikawa
@es
Satoshi Ichikawa
@nl
Satoshi Ichikawa
@sl
prefLabel
Satoshi Ichikawa
@ast
Satoshi Ichikawa
@en
Satoshi Ichikawa
@es
Satoshi Ichikawa
@nl
Satoshi Ichikawa
@sl
P106
P31
P496
0000-0001-5345-5007